183 related articles for article (PubMed ID: 36241145)
21. Feasibility of sending a direct send HPV self-sampling kit to long-term non-attenders in an organized cervical screening program.
Sahlgren H; Sparén P; Elfgren K; Miriam Elfström K
Eur J Obstet Gynecol Reprod Biol; 2022 Jan; 268():68-73. PubMed ID: 34875556
[TBL] [Abstract][Full Text] [Related]
22. Randomized Intervention of Self-Collected Sampling for Human Papillomavirus Testing in Under-Screened Rural Women: Uptake of Screening and Acceptability.
Racey CS; Gesink DC; Burchell AN; Trivers S; Wong T; Rebbapragada A
J Womens Health (Larchmt); 2016 May; 25(5):489-97. PubMed ID: 26598955
[TBL] [Abstract][Full Text] [Related]
23. Reactions of women underscreened for cervical cancer who received unsolicited human papillomavirus self-sampling kits.
Malone C; Tiro JA; Buist DS; Beatty T; Lin J; Kimbel K; Gao H; Thayer C; Miglioretti DL; Winer RL
J Med Screen; 2020 Sep; 27(3):146-156. PubMed ID: 31744374
[TBL] [Abstract][Full Text] [Related]
24. Human Papillomavirus Self-Sampling for Primary Cervical Cancer Screening in Under-Screened Women in Hong Kong during the COVID-19 Pandemic.
Ngu SF; Lau LSK; Li J; Wong GCY; Cheung ANY; Ngan HYS; Chan KKL
Int J Environ Res Public Health; 2022 Feb; 19(5):. PubMed ID: 35270303
[TBL] [Abstract][Full Text] [Related]
25. Assessing the impact of mailing self-sampling kits for human papillomavirus testing to unscreened non-responder women in Manitoba.
Jalili F; O'Conaill C; Templeton K; Lotocki R; Fischer G; Manning L; Cormier K; Decker K
Curr Oncol; 2019 Jun; 26(3):167-172. PubMed ID: 31285661
[TBL] [Abstract][Full Text] [Related]
26. For due or overdue cervical cancer screening, direct or opt-in mailing of HPV self-sampling increased screening at 6 mo vs. education.
Batur P
Ann Intern Med; 2024 Apr; 177(4):JC46. PubMed ID: 38560899
[TBL] [Abstract][Full Text] [Related]
27. The cost-effectiveness of opt-in and send-to-all HPV self-sampling among long-term non-attenders to cervical cancer screening in Norway: The Equalscreen randomized controlled trial.
Knauss T; Hansen BT; Pedersen K; Aasbø G; Kunst N; Burger EA
Gynecol Oncol; 2023 Jan; 168():39-47. PubMed ID: 36371904
[TBL] [Abstract][Full Text] [Related]
28. Turkish and Moroccan Dutch women's views of using a self-sampling kit for human papillomavirus testing as a tool for cervical cancer screening: What are the barriers and the motivators?
Hilverda F; Fissers K; van den Broek T
Womens Health (Lond); 2021; 17():17455065211065873. PubMed ID: 34903110
[TBL] [Abstract][Full Text] [Related]
29. HPV self-sampling among long-term non-attenders to cervical cancer screening in Norway: a pragmatic randomised controlled trial.
Aasbø G; Tropè A; Nygård M; Christiansen IK; Baasland I; Iversen GA; Munk AC; Christiansen MH; Presthus GK; Undem K; Bjørge T; Castle PE; Hansen BT
Br J Cancer; 2022 Nov; 127(10):1816-1826. PubMed ID: 35995936
[TBL] [Abstract][Full Text] [Related]
30. Perspectives of women participating in a cervical cancer screening campaign with community-based HPV self-sampling in rural western Kenya: a qualitative study.
Oketch SY; Kwena Z; Choi Y; Adewumi K; Moghadassi M; Bukusi EA; Huchko MJ
BMC Womens Health; 2019 Jun; 19(1):75. PubMed ID: 31196175
[TBL] [Abstract][Full Text] [Related]
31. Human papillomavirus self-sampling for long-term non-attenders in cervical cancer screening: A randomised feasibility study in Estonia.
Veerus P; Hallik R; Jänes J; Jõers K; Paapsi K; Laidra K; Innos K
J Med Screen; 2022 Mar; 29(1):53-60. PubMed ID: 34694179
[TBL] [Abstract][Full Text] [Related]
32. Understanding the Acceptability and Uptake of HPV Self-Sampling Amongst Women Under- or Never-Screened for Cervical Cancer in Toronto (Ontario, Canada): An Intervention Study Protocol.
Lofters A; Devotta K; Prakash V; Vahabi M
Int J Environ Res Public Health; 2021 Aug; 18(17):. PubMed ID: 34501703
[TBL] [Abstract][Full Text] [Related]
33. Preferred Location for Human Papillomavirus Self-Sampling for Cervical Cancer Screening.
Liebermann E; Fontenot HB; Lim E; Matsunaga M; Zimet G; Allen JD
J Obstet Gynecol Neonatal Nurs; 2023 Sep; 52(5):364-373. PubMed ID: 37355248
[TBL] [Abstract][Full Text] [Related]
34. Community-randomised controlled trial embedded in the Anishinaabek Cervical Cancer Screening Study: human papillomavirus self-sampling versus Papanicolaou cytology.
Zehbe I; Jackson R; Wood B; Weaver B; Escott N; Severini A; Krajden M; Bishop L; Morrisseau K; Ogilvie G; Burchell AN; Little J
BMJ Open; 2016 Oct; 6(10):e011754. PubMed ID: 27855089
[TBL] [Abstract][Full Text] [Related]
35. Reach and effectiveness of an HPV self-sampling intervention for cervical screening amongst under- or never-screened women in Toronto, Ontario Canada.
Devotta K; Vahabi M; Prakash V; Lofters A
BMC Womens Health; 2023 Jan; 23(1):36. PubMed ID: 36698140
[TBL] [Abstract][Full Text] [Related]
36. Integrated cervical cancer screening in Mayuge District Uganda (ASPIRE Mayuge): a pragmatic sequential cluster randomized trial protocol.
Nakisige C; Trawin J; Mitchell-Foster S; Payne BA; Rawat A; Mithani N; Amuge C; Pedersen H; Orem J; Smith L; Ogilvie G
BMC Public Health; 2020 Jan; 20(1):142. PubMed ID: 32005202
[TBL] [Abstract][Full Text] [Related]
37. Mailing human papillomavirus self-sampling kits to women under-screened for cervical cancer improved detection in cervical cancer screening in a general population study in Japan.
Nishimura Y; Matsuura M; Terada N; Nagao S; Shimada H; Isoyama K; Tamate M; Iwasaki M; Saito T
BMC Public Health; 2023 Mar; 23(1):473. PubMed ID: 36906527
[TBL] [Abstract][Full Text] [Related]
38. HPV self-sampling among women in the United States: preferences for implementation.
Garg A; Galvin AM; Griner SB; Rosberger Z; Daley EM; Thompson EL
Cancer Causes Control; 2024 Jan; 35(1):167-176. PubMed ID: 37633857
[TBL] [Abstract][Full Text] [Related]
39. Community cervical cancer screening: Barriers to successful home-based HPV self-sampling in Dabat district, North Gondar, Ethiopia. A qualitative study.
Megersa BS; Bussmann H; Bärnighausen T; Muche AA; Alemu K; Deckert A
PLoS One; 2020; 15(12):e0243036. PubMed ID: 33306681
[TBL] [Abstract][Full Text] [Related]
40. A study protocol for a cluster randomized pragmatic trial for comparing strategies for implementing primary HPV testing for routine cervical cancer screening in a large health care system.
Chao CR; Cannizzaro NT; Hahn EE; Tewari D; Ngo-Metzger Q; Hsu C; Shen E; Wride P; Hodeib M; Gould M; Mittman BS
Contemp Clin Trials; 2023 Jan; 124():106994. PubMed ID: 36336248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]